Literature DB >> 1349586

Immunogenetics of multiple sclerosis and optic neuritis: DNA polymorphism of HLA class II genes.

N Morling1, M Sandberg-Wollheim, L Fugger, J Georgsen, J J Hylding-Nielsen, H O Madsen, K Rieneck, L Ryder, A Svejgaard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1349586     DOI： 10.1007/bf00179795

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  27 in total

1.  Immunogenetic profile of multiple sclerosis in Mexicans.

Authors:  C Gorodezky; R Najera; B E Rangel; L E Castro; J Flores; G Velázquez; J Granados; J Sotelo
Journal:  Hum Immunol       Date:  1986-08       Impact factor: 2.850

2.  Possible correlation of TNF alpha-production with -RFLP in humans.

Authors:  L Fugger; K Bendtzen; N Morling; L Ryder; A Svejgaard
Journal:  Eur J Haematol       Date:  1989-09       Impact factor: 2.997

3.  Histocompatibility determinants in multiple sclerosis, with special reference to clinical course.

Authors:  C Jersild; T Fog; G S Hansen; M Thomsen; A Svejgaard; B Dupont
Journal:  Lancet       Date:  1973-12-01       Impact factor: 79.321

4.  Binding of immunogenic peptides to Ia histocompatibility molecules.

Authors:  B P Babbitt; P M Allen; G Matsueda; E Haber; E R Unanue
Journal:  Nature       Date:  1985 Sep 26-Oct 2       Impact factor: 49.962

5.  Restriction fragment length polymorphism of the HLA-DP subregion and correlations to HLA-DP phenotypes.

Authors:  J J Hyldig-Nielsen; N Morling; N Odum; L P Ryder; P Platz; B Jakobsen; A Svejgaard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

6.  HLA-DP beta and susceptibility to multiple sclerosis: an analysis of caucasoid and Japanese patient populations.

Authors:  A B Begovich; R C Helmuth; J R Oksenberg; K Sakai; T Tabira; T Sasazuki; L Steinman; H A Erlich
Journal:  Hum Immunol       Date:  1990-08       Impact factor: 2.850

Review 7.  Diagnosis and classification of multiple sclerosis.

Authors:  W I McDonald; A M Halliday
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

8.  Different B lymphocyte alloantigens associated with multiple sclerosis in Arabs and North Europeans.

Authors:  A Kurdi; I Ayesh; A Abdallat; U Maayta
Journal:  Lancet       Date:  1977-05-28       Impact factor: 79.321

9.  T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.

Authors:  K Ota; M Matsui; E L Milford; G A Mackin; H L Weiner; D A Hafler
Journal:  Nature       Date:  1990-07-12       Impact factor: 49.962

10.  Tumor necrosis factor alpha gene polymorphism in multiple sclerosis and optic neuritis.

Authors:  L Fugger; N Morling; M Sandberg-Wollheim; L P Ryder; A Svejgaard
Journal:  J Neuroimmunol       Date:  1990-04       Impact factor: 3.478
View more
  1 in total

1.  CD24 is a genetic modifier for risk and progression of multiple sclerosis.

Authors:  Qunmin Zhou; Kottil Rammohan; Shili Lin; Nikki Robinson; Ou Li; Xingluo Liu; Xue-feng Bai; Lijie Yin; Bruce Scarberry; Peishuang Du; Ming You; Kunliang Guan; Pan Zheng; Yang Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.